Skip to main content
logo
INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.560
-0.170 (-6.23%)
At close: Aug 1, 2025, 4:00 PM
2.600
+0.040 (1.56%)
After-hours: Aug 1, 2025, 7:48 PM EDT

INmune Bio Employees

As of December 31, 2024, INmune Bio had 22 total employees, including 13 full-time and 9 part-time employees. The number of employees increased by 5 or 29.41% compared to the previous year.

Employees
22
Change (1Y)
5
Growth (1Y)
29.41%
Revenue / Employee
$2,273
Profits / Employee
-$1,854,364
Market Cap
68.06M

Employees Chart

Employees History

DateEmployeesChangeGrowth
Dec 31, 202422529.41%
Dec 31, 202317770.00%
Dec 31, 2022100-
Dec 31, 2021105100.00%
Dec 31, 20205125.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company NameEmployees
UnitedHealth Group400,000
Johnson & Johnson138,100
Thermo Fisher Scientific125,000
Abbott Laboratories114,000
AstraZeneca94,300
Novo Nordisk77,349
Novartis AG75,883
Merck & Co.75,000
Employee Rankings

INMB News

More News